Next Article in Journal
Rapid Discrimination of Methicillin-Resistant Staphylococcus aureus by MALDI-TOF MS
Previous Article in Journal
Resistome Profiles, Plasmid Typing, and Whole-Genome Phylogenetic Tree Analyses of BlaNDM-9 and Mcr-1 Co-Harboring Escherichia coli ST617 from a Patient without a History of Farm Exposure in Korea
Previous Article in Special Issue
Human Herpesvirus Sequencing in the Genomic Era: The Growing Ranks of the Herpetic Legion
Open AccessArticle

The Current Status of Cytomegalovirus (CMV) Prevalence in the MENA Region: A Systematic Review

1
Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, Doha, PO Box 2713, Qatar
2
Biomedical Research Center, Qatar University, Doha, PO Box 2713, Qatar
*
Author to whom correspondence should be addressed.
Pathogens 2019, 8(4), 213; https://doi.org/10.3390/pathogens8040213
Received: 29 September 2019 / Revised: 19 October 2019 / Accepted: 21 October 2019 / Published: 31 October 2019
(This article belongs to the Special Issue Human Herpesviruses: Diversity and Disease)
Human cytomegalovirus (CMV) is a highly prevalent herpesvirus worldwide. According to the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO), CMV infects people of all ages, and by the age of five, approximately one-third of children in the United States are infected. Although the infection is generally asymptomatic, it can cause severe disease in immunocompromised patients, transplant and transfusion recipients, as well as newborn neonates. The objective of this study is to systematically review published literature on CMV in the MENA region to estimate its incidence in the region and describe its epidemiological and clinical significance. The literature was searched through four scientific databases: PubMed, Scopus, Science Direct, and Web of Science. A total of 72 studies from 11 countries satisfied the inclusion criteria, covering a period from 1988–2019. The CMV IgG seroprevalence ranged from 8.7%–99.2% (SD = 38.95%). CMV incidence in these countries ranged between 1.22% and 77% in transplant and transfusion recipients, with an increase in incidence with advanced age. However, the incidence rate was unclear for congenital CMV due to the variability of the reporting. This review highlights the need for more robust and well-designed studies to better estimate CMV incidence in the MENA region, standardize diagnostic criteria, and consider prophylactic and pre-emptive treatments to limit the morbidity and mortality of the disease. View Full-Text
Keywords: cytomegalovirus; transplantation; transfusion; congenital; MENA region cytomegalovirus; transplantation; transfusion; congenital; MENA region
Show Figures

Figure 1

MDPI and ACS Style

Al Mana, H.; Yassine, H.M.; Younes, N.N.; Al-Mohannadi, A.; Al-Sadeq, D.W.; Alhababi, D.; Nasser, E.A.; Nasrallah, G.K. The Current Status of Cytomegalovirus (CMV) Prevalence in the MENA Region: A Systematic Review. Pathogens 2019, 8, 213.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop